Press release
Global Male Hypogonadism Market Projected to Surpass $5.08 Billion by 2029 with 6% Annual Growth
The rise in infertility rates is anticipated to boost the expansion of the male hypogonadism market in the future. Infertility is a condition that affects the reproductive system of males or females, marked by the inability to conceive after a year or more of regular, unprotected sexual intercourse. Male hypogonadism, which might result in reduced sperm production and infertility, is a possible root of male infertility. Consequently, the growing frequency of male infertility is projected to fuel the male hypogonadism market's growth. For example, the Office for National Statistics, a government department in the UK, reported in February 2024 that the total fertility rate (TFR) rose to 1.49 children per woman in 2022, up from 1.55 in 2021. As such, the ascent in the infertility rate is propelling the male hypogonadism market's growth.
Get Your Male Hypogonadism Market Report Here:
https://www.thebusinessresearchcompany.com/report/male-hypogonadism-global-market-report
What Is the projected market size and growth rate for the male hypogonadism market?
Over the past few years, the market size of male hypogonadism has seen substantial growth. The sector's value is set to increase from $3.75 billion in 2024 to $3.99 billion in 2025, registering a compound annual growth rate (CAGR) of 6.3%. This growth during the historical period can be credited to factors such as the aging population, increased awareness and diagnosis, lifestyle conditions, chronic diseases, and the behavior of seeking treatments.
Anticipated to witness robust growth in the coming years, the male hypogonadism market is projected to expand to $5.08 billion in 2029 with a compound annual growth rate (CAGR) of 6.2%. The progression during the projected period can be linked to increased awareness, the incidence of conditions related to lifestyle, therapeutic innovations, attention on men's wellbeing, telemedicine, and more accessible healthcare. The forecasted period is likely to see growing concern for psychological and sexual health, exploration of nutraceuticals and lifestyle interventions, market widening in developing nations, combined research efforts, and a focus on prolonged safety and monitoring.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9969&type=smp
What new trends are reshaping the male hypogonadism market and its opportunities?
A key trend observed gaining traction in the male hypogonadism market is the innovation of new products. To maintain their market position, businesses in the male hypogonadism industry are developing new products. For instance, in June 2022, Halozyme, a biotechnology company based in the US, introduced Tlando, a new oral treatment for testosterone replacement therapy for men suffering from hypogonadism. Tlando, a drug that contains testosterone, has the unique distinction of being the first orally-administered testosterone therapy to receive FDA approval. The drug is used to treat adult men whose testosterone levels are low or nonexistent due to certain medical conditions.
What major market segments define the scope and growth of the male hypogonadism market?
The male hypogonadism market covered in this report is segmented -
1) By Type: Klinefelters Syndrome, Kallmann Syndrome, Pituitary Disorders, Other Types
2) By Drug Delivery: Topical Gels, Injectables, Transdermal Patches, Other Drug Deliveries
3) By Therapy: Testosterone Therapy, Gonadotropin-Releasing Hormone Therapy
Subsegments:
1) By Klinefelter's Syndrome: 47,XXY Syndrome, Other Variants
2) By Kallmann Syndrome: Isolated Kallmann Syndrome, Syndromic Kallmann Syndrome
3) By Pituitary Disorders: Hypopituitarism, Pituitary Tumors, Other Pituitary Disorders
4) By Other Types: Androgen Insensitivity Syndrome, Testicular Dysgenesis Syndrome, Genetic Mutations And Disorders
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9969
Which region dominates the male hypogonadism market?
North America was the largest region in the male hypogonadism market in 2024. Asia-Pacific is expected to be the fastest-growing region in the male hypogonadism market report during the forecast period. The regions covered in the male hypogonadism market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Which key market leaders are driving the male hypogonadism industry growth?
Major companies operating in the male hypogonadism market include Pfizer Inc., Bayer AG, Eli Lilly and Company Ltd., Endo International plc., Merck & Co. Inc., Ferring Pharmaceuticals, Finox Biotech AG, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Perrigo Company plc, IBSA Institut Biochimique SA, Sun Pharmaceutical Industries Limited, Glenmark Pharmaceuticals Limited, Antares Pharma Inc., Zydus Cadila LLC, Besins Healthcare Ltd., Clarus Therapeutics Holdings Inc., Foresee Pharmaceuticals Co. Ltd., Lipocine Inc., Myovant Sciences Ltd., Sandoz International GmbH, Shionogi & Co. Ltd., TherapeuticsMD Inc., Viking Therapeutics Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=9969&type=smp
What Is Covered In The Male Hypogonadism Global Market Report?
• Market Size Forecast: Examine the male hypogonadism market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the male hypogonadism market for a structured understanding.
• Key Players Overview: Analyze major players in the male hypogonadism market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the male hypogonadism market.
• Segment Contributions: Evaluate how different segments drive overall growth in the male hypogonadism market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the male hypogonadism market.
• Industry Challenges: Identify potential risks and obstacles affecting the male hypogonadism market.
• Competitive Landscape: Review strategic developments in the male hypogonadism market, including expansions, agreements, and new product launches.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.
Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Male Hypogonadism Market Projected to Surpass $5.08 Billion by 2029 with 6% Annual Growth here
News-ID: 3893054 • Views: …
More Releases from The Business Research Company
Global High-Resolution Anoscopy Market Outlook 2025-2034: Trends, Innovations, A …
The High-Resolution Anoscopy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the High-Resolution Anoscopy Market Size and Projected Growth Rate?
The market size for high-resolution anoscopy has experienced significant growth over the past few years. The market is predicted to increase from $15.03 billion…
Condyloma Acuminata Treatment Market Size Projected To Reach $2.2 Billion By 203 …
"The Condyloma Acuminata Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Condyloma Acuminata Treatment Market Size During the Forecast Period?
In the past few years, the condyloma acuminata treatment market has seen significant growth. The market value, which is anticipated to…
Household Type Fans Market Forecast 2025-2034: Comprehensive Analysis And Growth …
"The Household Type Fans Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Household Type Fans Market?
The market size for household fans has seen consistent expansion in recent years. The projections indicate an increase from $32.22 billion in 2024…
Grain Fumigants Industry Report 2025-2034: Market Dynamics, Trends, And Forecast …
The Grain Fumigants Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Grain Fumigants Market Size During the Forecast Period?
The Grain Fumigants Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This…
More Releases for Syndrome
"Understanding Rett Syndrome: Trends and Advances in the Rett Syndrome Market"
The Rett Syndrome Market, valued at USD 225.02 million in 2022, is anticipated to surge to USD 515.06 million by 2029, reflecting a significant Compound Annual Growth Rate (CAGR) of 10.23% from 2023 to 2029.
Overview of the Rett Syndrome Market:
Rett syndrome, a rare genetic neurological and developmental disorder primarily impacting females, hinders brain development and causes progressive loss of motor skills and language. The market report underscores technological advancements…
MISME Syndrome Market - Navigating Challenges, Embracing Abilities: MISME Syndro …
Newark, New Castle, USA: The "MISME Syndrome Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
MISME Syndrome Market: https://www.growthplusreports.com/report/misme-syndrome-market/8883
This latest report researches the industry structure, sales, revenue,…
Felty Syndrome Market - A Dedicated Approach to Felty Syndrome Care and Empowerm …
Newark, New Castle, USA: The "Felty Syndrome Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Felty Syndrome Market: https://www.growthplusreports.com/report/felty-syndrome-market/8440
This latest report researches the industry structure, sales, revenue,…
MISME Syndrome Market - Transforming Lives: Empowering Recovery from MISME Syndr …
Newark, New Castle, USA - new report, titled MISME Syndrome Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the MISME Syndrome market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global MISME Syndrome market. The report offers an overview of the market, which…
Hepatorenal Syndrome Market - Reimagining Wellness, Redefining Survival: Hepator …
Newark, New Castle, USA - new report, titled Hepatorenal Syndrome Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Hepatorenal Syndrome market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Hepatorenal Syndrome market. The report offers an overview of the market, which…
Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syn …
Global Markets Directs, Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2016, provides an overview of the Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and…
